Skip to main content
. 2019 Sep 27;39(10):618–626. doi: 10.1089/jir.2019.0048

FIG. 3.

FIG. 3.

Decline in HCV RNA levels in response to treatment with peg-IFNα/ribavirin among African American participants in the Virahep-C Trial. Genotype for IFNL4-ΔG/TT was a stronger predictor than that for GWAS marker IFNL4-rs12979860 (P = 0.015) (Prokunina-Olsson and others 2013).